跳至主要内容
临床试验/TCTR20181218003
TCTR20181218003Enrolling By Invitation2 期

Comparative Study of Efficacy and Safety of Roselle Tablet and Amlodipine in Patients with Mild Hypertension (Clinical Trial Phase II)

Center of Excellence in applied Thai Traddional Medicine0 个研究点目标入组 78 人开始时间: 2018年12月18日最近更新:
适应症

试验速览

阶段
2 期
状态
Enrolling By Invitation
发起方
入组人数
78

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 Years 至 70 Years(—)
性别
All

入选标准

  • • Age between 40-70 years
  • • Diagnosed with mild hypertension (systolic 140-159 mmHg, diastolic 90-99 mmHg )
  • • Never have no received antihypertensive treatment or Ever have received only one type of Antihypertensive drug
  • • Have no received antihypertensive treatment at least for 2 weeks prior to study
  • • Results of Electrocardiogram (EKG) have no abnormal QT interval, ST segment changing and no pathologic Q wave
  • • Must have granted consent for participation in this clinical investigation

排除标准

  • • Patient with diabetes, nephropathy, Cardiopathy, hepatic disease and cancer were excluded
  • • Have potassium less than 3.4 mmol/L
  • • Pregnant women, patient with evidence of secondary hypertension, chronic smokers and alcoholics were excluded
  • • Be allergic in Roselle or Amlodipine
  • • Who did not complete the study

研究者

发起方
Center of Excellence in applied Thai Traddional Medicine

相似试验